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Objectives 
• Understand providers’ perspectives on factors impacting opioid prescription in cancer.  
• Illustrate the differences and similarities in diverse cultural and political contexts.  
Importance. To understand how cultural and political difference ca impact perspectives on opioid 
therapy in cancer.  
Objective(s). 1. To understand providers perspectives on factors impacting opioid prescription in 
cancer. 2. To illustrate the differences and similarities in diverse cultural and political contexts.  
Method(s). Using similar but contextually tailored semi-structured interview guides, we conducted 
two separate qualitative studies in the U.S. and Australia. We captured the perspectives of 43 
providers: 10 general practitioners (GP) and 10 oncology providers (ONC) in the US. Department of 
Veterans Affairs, 20 GPs and 3 ONCs in Australia. Qualitative content analysis method was used in 
each study and then the emerging themes were compared across studies.  
Results. 1) Patient characteristics impacting decision: Providers in both contexts cited patient 
prognosis, diversion by patients’ family (It’s a very common story, obtaining opioids from family 
members), goals for pain management, important contextual factors (e.g. history of substance 
misuse, mental health), the cause, type and quality of pain as factors important in assessment for 
opioid therapy 2) Barriers to shared decision making: Both specified limited clinical time and 
inadequate communication between providers. 3) Facilitators to shared decision making: Both 
mentioned having an established therapeutic relationship with the patient. 4) The title cancer: Both 
quoted ‘‘cancer’’ makes them ‘‘a little more liberal with opiate use.’’ Australian GPs specifically 
mentioned that providers might ‘‘have a soft heart for the cancer patients’’ and are blinded by this 
title. 5) Use of alternative prescription: Australian providers mentioned opioid alternatives are 
lacking and its simpler ‘‘to write doses of Oxycontin than to get people involved in multi-disciplinary 
team.’’ Only American prescribers mentioned burdens associated with maintaining patients on 
opioids. 
Conclusion(s). Factors were largely similar in both contexts with some notable contextual 
differences. Impact. This qualitative study looks at two international contexts; the differences 
highlight the importance of further international comparisons regarding best practices and policies. 
